ZU Logo
Home  |  Online Registration  |  eLearning  | Contact Us  |  عربي  


Researcher Name
B Ala'a, Malik Sallam, Asem Rebhi, Laarni Soliman, Lina Al Sarayrih, Zeinab Tarhini, Rana Abutaima, Musheer A Aljaberi, Muna Barakat
Name Of Journal
Narra J
Volume No.
2(3):e97
Date Of Publication
2022.12
Abstract
Ebola virus disease (EVD) is a rare but highly contagious and lethal disease that occurs predominantly in African countries, with a case-fatality rate of 30–90%. The causative viral pathogens of EVD are within the genus Ebolavirus in the family Filoviridae. The primary route of human-to-human transmission is through direct contact with blood, bodily fluids and secretions from infected individuals. Direct contact with virally contaminated objects and sexual transmission have also been reported. Management of EVD is aggressive supportive care with possibly new therapeutic options. On 20 September 2022, an EVD outbreak was declared in Uganda, caused by Sudan ebolavirus. As of 7 November 2022, a total of 136 confirmed cases, 53 confirmed deaths have been reported, including 18 cases with seven deaths among healthcare workers. In the Democratic Republic of Congo (DRC), an EVD outbreak was also declared on 22 August 2022 (which ended on 27 September 2022); with only one case, a middle-aged w
File
View File